PSON enters September with a story shaped more by its ownership structure than by its lending market — and at the centre of that story is a 19.4% stake held by activist investor Cevian Capital.
The ownership picture is the single most compelling fact about Pearson right now. Cevian, the Swedish activist known for pushing underperforming European industrials toward restructuring and capital returns, added roughly 1.8 million shares in the period to August 3, lifting its holding to 116.8 million shares — nearly a fifth of the company. Artisan Partners sits in second place at 12%, also adding almost 4 million shares over the same period. BlackRock rounds out the top three at 7.97%, likewise a net buyer. Three of the four largest holders are building positions. The contrast sits with Artemis Investment Management, which trimmed by 7.5 million shares — a reduction worth roughly £91 million at current prices — making it the most significant seller in the register.
Short positioning does not add meaningful pressure here. Short interest runs near 6% of free float, a level that was noted as "modest" in a recent note on the name, and the borrow market reflects that ease. Availability is extremely loose — for every share currently borrowed, more than four and a half remain available in the lending pool, and that ratio actually widened on Tuesday to 455% from around 420% at the end of last week. Cost to borrow is negligible at 0.57%, having drifted within a tight band all summer. Nothing in the lending market suggests a coordinated short campaign; availability has not tightened below 312% at any point in the past year, confirming the borrow pool remains deep. The ORTEX short score at 61.6 is mid-range and has nudged only marginally higher over the past two weeks, consistent with a market that is watching rather than pressing.
The Street is cautious on valuation rather than bearish on the business. Nine of the ten analysts covering PSON carry a hold rating, with a single buy. The consensus price target of £12.42 sits almost exactly where the stock trades at £12.26 — implying the market is fairly priced at current levels in analyst eyes. Multiples tell a similar story: the P/E ratio of 16.1x has compressed by roughly 1.5 turns over the past month, while EV/EBITDA at 9.75x has barely moved. The dividend score factor ranks in the 83rd percentile, pointing to above-average income credentials, though the dividend data in this dataset is stale and should not be taken as current. The forward EPS growth factor ranks in the 77th percentile — a meaningful positive — while the EPS surprise factor is weak at the 30th percentile, meaning Pearson has generally delivered below-expectation beats in recent prints.
That earnings track record is worth noting in its own right. The most recent result, reported on July 31, pushed the stock down 3.3% on the day and 5.3% over the following five days — a meaningful negative reaction. The prior event in late July 2026 produced a 6.9% gain on the day before fading. Reaction swings of that magnitude around earnings matter when the next event is just six weeks out, on October 12.
Among correlated peers, LRN added 2.6% on the week while COUR gained 2.7%, suggesting the broader education sector caught a bid. PSON managed only a 0.9% weekly gain and closed Tuesday marginally lower, modestly underperforming the group. GHC was the week's notable laggard, falling 6.6%.
The October 12 earnings date is therefore the focal point — how Pearson frames its digital learning transition and whether Cevian's continued accumulation is accompanied by any public push for strategic change will determine whether the current holding pattern resolves to the upside or repeats the post-results selloff seen in July.
See the live data behind this article on ORTEX.
Open PSON on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
